CClinicalTrials.gg
CompletedNCT02176954Updated Mar 23, 2015

The Influence of Adhesive Wafer Design on Fit to the Body

An interventional study of Test A and Test B in Ostomy - Ileostomy or Colostomy, sponsored by Coloplast A/S. Completed at 10 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-23.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to investigate the influence of the adhesive wafer design on the products ability to fit to the body..

02

Conditions studied

  • Ostomy - Ileostomy or Colostomy
03

In context

Lead sponsor

Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

To participate in the study, it is mandatory that the subject fulfill all inclusions criteria:

  • Have given written informed consent and signed letter of Authority
  • Be at least 18 years of age and have full legal capacity
  • Have had their ileostomy or colostomy for at least 3 months
  • Have a stoma with a diameter between 15 and 43 mm
  • Be able to handle the product themselves
  • Be able to use a custom cut product
  • Normally experience faeces under the adhesive wafer at least 3 times during 2 weeks
  • Currently using a 1-piece flat product or a 1-piece soft convex product
  • Be willing to test products with open bag size maxi
  • Be willing to test Moderma Flex or Confidence® Natural, Drainable and the two test products A and B
  • Be willing to use minimum 1 test product every second day, i.e. maximum 48 hours wear time per product
  • Be suitable for participating in the investigation
  • Be willing to take/have taken pictures of the stoma before, during and after application of product

Exclusion criteria

Exclusion Criteria:

Subjects complying with the following criteria must be excluded from participation in the clinical investigation:

  • Are currently receiving or have within the past 2 months received radio-and/or chemotherapy
  • Are currently receiving or have within the past month received topical steroid treatment in the peri-stomal skin area or systemic steroid (tablet/injection) treatment
  • Are pregnant or breastfeeding
  • Are participating in other interventional clinical investigations or have previously participated in this investigation
  • Use irrigation during the investigation (flush the intestines with water)
  • Are currently suffering from peri-stomal skin problems i.e. bleeding and/or broken skin (assessed by the study nurse)
  • Have a loop stoma
  • Have known hypersensitivity towards any of the test products
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Test A, Test B, Comparator

    The subjects first test Coloplast Test A followed by Coloplast Test B and finally Comparator.

    Device: Test A · Device: Test B · Device: Comparator

  • Experimental
    Test A, Comparator, Test B

    The subjects first test Coloplast Test A followed by Comparator and finally Coloplast Test B.

    Device: Test A · Device: Test B · Device: Comparator

  • Experimental
    Test B, Test A, Comparator

    The subjects first test Coloplast Test B followed by Coloplast Test A and finally Comparator.

    Device: Test A · Device: Test B · Device: Comparator

  • Experimental
    Test B, Comparator, Test A

    The subjects first test Coloplast Test B followed by Comparator and finally Coloplast Test B.

    Device: Test A · Device: Test B · Device: Comparator

  • Experimental
    Comparator, Test A, Test B

    The subjects first test Comparator followed by Coloplast Test A and then Coloplast Test B

    Device: Test A · Device: Test B · Device: Comparator

  • Experimental
    Comparator, Test B, Test A

    The subjects first test Comparator followed by Coloplast Test B and then Coloplast Test A.

    Device: Test A · Device: Test B · Device: Comparator

Interventions

  • DeviceTest A

    Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

  • DeviceTest B

    Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

  • DeviceComparator

    Two comparators will be used: Moderma Flex (Hollister) or Confidence Natural drainable (Salts).These product are commercially available. Subjects will be randomized into one of twelwe arms. Data will be analyzed by pooling the two comparators, Moderma Flex and Confidence Natural, Drainable, why six arms are displayed.

06

What researchers measure

Primary outcomes

  1. Fit to body

    Subjects will evaluate the fit to body for each product by answering the question "How was the base plates ability to fit the body contours in the area around the stoma?" The question is answered with a 5-point scale ranging from Very Poor - Very Good (1-5), where the very poor (1) is the worst possible score and very good (5) is the best possible score.

    Time frame: 14 +/- 2 days

07

Study locations

10 sites
  • QPS Netherlands
    Groningen, 9713, Netherlands
  • Synexus Thames Valley
    Berkshire, RG2 0TG, United Kingdom
  • Synexus Midlands
    Birmingham, B15 2SQ, United Kingdom
  • Synexus Wales
    Cardiff, CF14 5GJ, United Kingdom
  • Synexus Scotland
    Glasgow, G20 0SP, United Kingdom
  • Cheltenham General Hospital
    Gloucestershire, G1537AN, United Kingdom
  • Synesxus Lancashire
    Lancashire, PR7 7NA, United Kingdom
  • Synexus Merseyside
    Liverpool, L22 0LG, United Kingdom
  • Synexus Manchester
    Manchester, M15 6SX, United Kingdom
  • Synexus North East
    Northumberland, NE46 1QJ, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02176954
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
Jun 27, 2014
Start date
Jul 2014
Primary completion
Feb 2015
Completion
Mar 2015
Last update
Mar 23, 2015

Study contacts

Khalid Abd-Elaziz, MD
principal investigator · QPS Netherlands
Susanne Eyre, MD
principal investigator · Synexus North East, United Kingdom
Gillian Hopkins
principal investigator · Cheltenham General Hospital, United Kingdom

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion